Roundtable discussion on the advances in myeloma and benefit for patients

Bookmark and Share
Published: 13 Jan 2011
Views: 4361
Prof Gareth Morgan, Dr Faith Davies, Eric Lowe, Dr Stuart Smith
Prof Gareth Morgan, Dr Faith Davies and Eric Lowe, talking at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics, discuss how the data presented at the meeting will benefit patients being treated for myeloma.

The workshop was supported by an unrestricted medical education grant from the following companies; Celgene, Bristol Myers Squibb, Johnson and Johnson, Takeda Millennium, Novartis Oncology, Cephalon and Onyx Pharmaceuticals.